产后出血治疗何时开始?E-MOTIVE试验中的嵌套观察性研究。

IF 4.3 1区 医学 Q1 OBSTETRICS & GYNECOLOGY
Kristie-Marie Mammoliti, Fernando Althabe, Christina Easter, Adam Devall, James Martin, Adeosun Love Funmi, Rahmatu Yusuf, Fatima Abubakar, Lolade Christiana Arigbede, JimKelly Mugambi, Polycarp Oyoo, Masumbuko Sambusa, Akwinata Banda, Fawzia Samuels, Sara Willemse, Sibongile Doris Khambule, Hilal Mukhtar Shu'aib, Aminu Ado Wakili, Jenipher Okore, Ard Mwampashi, Mandisa Singata-Madliki, Edna Arends, Elani Muller, Hadiza Galadanci, Zahida Qureshi, Fadhlun Alwy Al-Beity, G. Justus Hofmeyr, Sue Fawcus, Neil Moran, George Gwako, Alfred Osoti, Ioannis Gallos, Arri Coomarasamy
{"title":"产后出血治疗何时开始?E-MOTIVE试验中的嵌套观察性研究。","authors":"Kristie-Marie Mammoliti,&nbsp;Fernando Althabe,&nbsp;Christina Easter,&nbsp;Adam Devall,&nbsp;James Martin,&nbsp;Adeosun Love Funmi,&nbsp;Rahmatu Yusuf,&nbsp;Fatima Abubakar,&nbsp;Lolade Christiana Arigbede,&nbsp;JimKelly Mugambi,&nbsp;Polycarp Oyoo,&nbsp;Masumbuko Sambusa,&nbsp;Akwinata Banda,&nbsp;Fawzia Samuels,&nbsp;Sara Willemse,&nbsp;Sibongile Doris Khambule,&nbsp;Hilal Mukhtar Shu'aib,&nbsp;Aminu Ado Wakili,&nbsp;Jenipher Okore,&nbsp;Ard Mwampashi,&nbsp;Mandisa Singata-Madliki,&nbsp;Edna Arends,&nbsp;Elani Muller,&nbsp;Hadiza Galadanci,&nbsp;Zahida Qureshi,&nbsp;Fadhlun Alwy Al-Beity,&nbsp;G. Justus Hofmeyr,&nbsp;Sue Fawcus,&nbsp;Neil Moran,&nbsp;George Gwako,&nbsp;Alfred Osoti,&nbsp;Ioannis Gallos,&nbsp;Arri Coomarasamy","doi":"10.1111/1471-0528.18293","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>To compare the frequency and timing of postpartum haemorrhage (PPH) treatment initiation between hospitals implementing the MOTIVE treatment bundle (which consisted of uterine Massage, Oxytocic drugs, Tranexamic acid, IntraVenous fluids and Examination) and those following usual care.</p>\n </section>\n \n <section>\n \n <h3> Design</h3>\n \n <p>Nested prospective observational study.</p>\n </section>\n \n <section>\n \n <h3> Setting</h3>\n \n <p>Hospitals in Nigeria, Kenya, Tanzania and South Africa participating in the E-MOTIVE trial.</p>\n </section>\n \n <section>\n \n <h3> Population or Sample</h3>\n \n <p>Healthcare workers treating PPH.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Between June and December 2022, we observed healthcare workers for 1–2 weeks in 39 E-MOTIVE and 39 usual care hospitals across Nigeria, Kenya, Tanzania, and South Africa managing vaginal birth and treating PPH. We descriptively compared the frequency and timing from PPH detection to treatment initiation of individual treatments and the MOTIVE bundle, between E-MOTIVE care and usual care.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Among 2578 observations in E-MOTIVE care hospitals, 295 (11%) PPHs were treated, and among 2834 observations in usual care hospitals, 219 (8%) PPHs were treated. In E-MOTIVE care hospitals, 97% (286/295) of women with PPH received the MOTIVE bundle, compared to 36% (79/219) in usual care. Median initiation times for the first component were similar (0 vs. 1 min), but E-MOTIVE care hospitals achieved faster initiation of all components (13 min, IQR 6–18) compared to usual care (18 min, IQR 10–25). In total, 79% (233/295) of women in E-MOTIVE care had all components initiated within 20 min, compared to 22% (48/219) in usual care.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Timely and comprehensive management of PPH using the MOTIVE bundle, particularly initiating all components within 15–20 min, was commonly observed in the E-MOTIVE care hospitals. Scaling up E-MOTIVE care should emphasise timely bundle initiation to strengthen PPH treatment and improve maternal health outcomes in low-and-middle-income countries.</p>\n </section>\n </div>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"132 11","pages":"1664-1672"},"PeriodicalIF":4.3000,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://obgyn.onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.18293","citationCount":"0","resultStr":"{\"title\":\"When Is Postpartum Haemorrhage Treatment Initiated? A Nested Observational Study Within the E-MOTIVE Trial\",\"authors\":\"Kristie-Marie Mammoliti,&nbsp;Fernando Althabe,&nbsp;Christina Easter,&nbsp;Adam Devall,&nbsp;James Martin,&nbsp;Adeosun Love Funmi,&nbsp;Rahmatu Yusuf,&nbsp;Fatima Abubakar,&nbsp;Lolade Christiana Arigbede,&nbsp;JimKelly Mugambi,&nbsp;Polycarp Oyoo,&nbsp;Masumbuko Sambusa,&nbsp;Akwinata Banda,&nbsp;Fawzia Samuels,&nbsp;Sara Willemse,&nbsp;Sibongile Doris Khambule,&nbsp;Hilal Mukhtar Shu'aib,&nbsp;Aminu Ado Wakili,&nbsp;Jenipher Okore,&nbsp;Ard Mwampashi,&nbsp;Mandisa Singata-Madliki,&nbsp;Edna Arends,&nbsp;Elani Muller,&nbsp;Hadiza Galadanci,&nbsp;Zahida Qureshi,&nbsp;Fadhlun Alwy Al-Beity,&nbsp;G. Justus Hofmeyr,&nbsp;Sue Fawcus,&nbsp;Neil Moran,&nbsp;George Gwako,&nbsp;Alfred Osoti,&nbsp;Ioannis Gallos,&nbsp;Arri Coomarasamy\",\"doi\":\"10.1111/1471-0528.18293\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Objective</h3>\\n \\n <p>To compare the frequency and timing of postpartum haemorrhage (PPH) treatment initiation between hospitals implementing the MOTIVE treatment bundle (which consisted of uterine Massage, Oxytocic drugs, Tranexamic acid, IntraVenous fluids and Examination) and those following usual care.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Design</h3>\\n \\n <p>Nested prospective observational study.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Setting</h3>\\n \\n <p>Hospitals in Nigeria, Kenya, Tanzania and South Africa participating in the E-MOTIVE trial.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Population or Sample</h3>\\n \\n <p>Healthcare workers treating PPH.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Between June and December 2022, we observed healthcare workers for 1–2 weeks in 39 E-MOTIVE and 39 usual care hospitals across Nigeria, Kenya, Tanzania, and South Africa managing vaginal birth and treating PPH. We descriptively compared the frequency and timing from PPH detection to treatment initiation of individual treatments and the MOTIVE bundle, between E-MOTIVE care and usual care.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Among 2578 observations in E-MOTIVE care hospitals, 295 (11%) PPHs were treated, and among 2834 observations in usual care hospitals, 219 (8%) PPHs were treated. In E-MOTIVE care hospitals, 97% (286/295) of women with PPH received the MOTIVE bundle, compared to 36% (79/219) in usual care. Median initiation times for the first component were similar (0 vs. 1 min), but E-MOTIVE care hospitals achieved faster initiation of all components (13 min, IQR 6–18) compared to usual care (18 min, IQR 10–25). In total, 79% (233/295) of women in E-MOTIVE care had all components initiated within 20 min, compared to 22% (48/219) in usual care.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>Timely and comprehensive management of PPH using the MOTIVE bundle, particularly initiating all components within 15–20 min, was commonly observed in the E-MOTIVE care hospitals. Scaling up E-MOTIVE care should emphasise timely bundle initiation to strengthen PPH treatment and improve maternal health outcomes in low-and-middle-income countries.</p>\\n </section>\\n </div>\",\"PeriodicalId\":50729,\"journal\":{\"name\":\"Bjog-An International Journal of Obstetrics and Gynaecology\",\"volume\":\"132 11\",\"pages\":\"1664-1672\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-08-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://obgyn.onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.18293\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bjog-An International Journal of Obstetrics and Gynaecology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://obgyn.onlinelibrary.wiley.com/doi/10.1111/1471-0528.18293\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bjog-An International Journal of Obstetrics and Gynaecology","FirstCategoryId":"3","ListUrlMain":"https://obgyn.onlinelibrary.wiley.com/doi/10.1111/1471-0528.18293","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的比较采用MOTIVE治疗方案(包括子宫按摩、催产药物、氨甲环酸、静脉输液和检查)的医院与常规护理的医院产后出血(PPH)开始治疗的频率和时间。设计嵌套前瞻性观察研究。尼日利亚、肯尼亚、坦桑尼亚和南非的医院参与了E-MOTIVE试验。人群或样本:治疗PPH的医护人员。方法在2022年6月至12月期间,我们在尼日利亚、肯尼亚、坦桑尼亚和南非的39家E-MOTIVE医院和39家普通护理医院观察了1-2周的医护人员,这些医院负责阴道分娩和治疗PPH。我们描述性地比较了从PPH检测到个体治疗开始的频率和时间,以及E-MOTIVE护理和常规护理之间的MOTIVE bundle。结果在E-MOTIVE护理医院2578例患者中,治疗了295例(11%),在普通护理医院2834例患者中,治疗了219例(8%)。在E-MOTIVE护理医院,97% (286/295)PPH妇女接受了MOTIVE捆绑治疗,而在常规护理中,这一比例为36%(79/219)。第一个成分的起始时间中位数相似(0 vs. 1分钟),但E-MOTIVE护理医院与常规护理(18分钟,IQR 10-25)相比,所有成分的起始时间更快(13分钟,IQR 6-18)。总的来说,79%(233/295)接受E-MOTIVE治疗的妇女在20分钟内启动了所有组件,而常规治疗的这一比例为22%(48/219)。结论在E-MOTIVE护理医院中,及时、全面地使用MOTIVE治疗方案,特别是在15-20分钟内启动所有组件,是PPH管理的普遍现象。扩大E-MOTIVE护理应强调及时启动捆绑治疗,以加强PPH治疗并改善低收入和中等收入国家的孕产妇健康结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

When Is Postpartum Haemorrhage Treatment Initiated? A Nested Observational Study Within the E-MOTIVE Trial

When Is Postpartum Haemorrhage Treatment Initiated? A Nested Observational Study Within the E-MOTIVE Trial

When Is Postpartum Haemorrhage Treatment Initiated? A Nested Observational Study Within the E-MOTIVE Trial

When Is Postpartum Haemorrhage Treatment Initiated? A Nested Observational Study Within the E-MOTIVE Trial

When Is Postpartum Haemorrhage Treatment Initiated? A Nested Observational Study Within the E-MOTIVE Trial

Objective

To compare the frequency and timing of postpartum haemorrhage (PPH) treatment initiation between hospitals implementing the MOTIVE treatment bundle (which consisted of uterine Massage, Oxytocic drugs, Tranexamic acid, IntraVenous fluids and Examination) and those following usual care.

Design

Nested prospective observational study.

Setting

Hospitals in Nigeria, Kenya, Tanzania and South Africa participating in the E-MOTIVE trial.

Population or Sample

Healthcare workers treating PPH.

Methods

Between June and December 2022, we observed healthcare workers for 1–2 weeks in 39 E-MOTIVE and 39 usual care hospitals across Nigeria, Kenya, Tanzania, and South Africa managing vaginal birth and treating PPH. We descriptively compared the frequency and timing from PPH detection to treatment initiation of individual treatments and the MOTIVE bundle, between E-MOTIVE care and usual care.

Results

Among 2578 observations in E-MOTIVE care hospitals, 295 (11%) PPHs were treated, and among 2834 observations in usual care hospitals, 219 (8%) PPHs were treated. In E-MOTIVE care hospitals, 97% (286/295) of women with PPH received the MOTIVE bundle, compared to 36% (79/219) in usual care. Median initiation times for the first component were similar (0 vs. 1 min), but E-MOTIVE care hospitals achieved faster initiation of all components (13 min, IQR 6–18) compared to usual care (18 min, IQR 10–25). In total, 79% (233/295) of women in E-MOTIVE care had all components initiated within 20 min, compared to 22% (48/219) in usual care.

Conclusions

Timely and comprehensive management of PPH using the MOTIVE bundle, particularly initiating all components within 15–20 min, was commonly observed in the E-MOTIVE care hospitals. Scaling up E-MOTIVE care should emphasise timely bundle initiation to strengthen PPH treatment and improve maternal health outcomes in low-and-middle-income countries.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
10.90
自引率
5.20%
发文量
345
审稿时长
3-6 weeks
期刊介绍: BJOG is an editorially independent publication owned by the Royal College of Obstetricians and Gynaecologists (RCOG). The Journal publishes original, peer-reviewed work in all areas of obstetrics and gynaecology, including contraception, urogynaecology, fertility, oncology and clinical practice. Its aim is to publish the highest quality medical research in women''s health, worldwide.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信